Rubén Domínguez
Story Poster
10:26
Hoops transfer Marcus Hill outlines goals for first season in Aggieland
1 mo ago by Luke Evangelist
After leading NC State with 11.5 points per game last season, Marcus Hill transferred to Texas A&M to play for Bucky McMillan. As he adjusts to life in Aggieland, Hill sat down for an exclusive interview to discuss his game, journey to College Station and more.
Story Poster
10:43
Former guard Mark French is excited for new era of Aggie basketball
1 mo ago by David Nuño
In the heat of the basketball offseason, former Texas A&M guard Mark French joined Wednesday's edition of TexAgs Live to speak on a new era of hoops in Aggieland. French shares his thoughts on Bucky McMillan's style of play, the roster and more.
Story Poster
Bucky McMillan's Aggies continuing to grind through summer workouts
1 mo ago by Luke Evangelist
Summer workouts are in full swing in Aggieland as Bucky McMillan prepares his first Texas A&M squad for the 2025-2026 campaign. As the calendar turns to July, the entire roster has reported to College Station, and the "Bucky Ball" foundation is officially being laid.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
32:11
Lunch with Liucci: Billy Liucci joins TexAgs Live (Friday, June 6)
2 mo ago by Billy Liucci
TexAgs' co-owner and executive editor Billy Liucci joined TexAgs Live on Friday morning to share his thoughts on Bucky McMillan's latest addition in Rubén Domínguez. Liucci also discussed A&M Athletics' Hall of Fame Class of 2025, including Dan Campbell and Ryan Swope.
Story Poster
Spanish guard Rubén Domínguez commits to Texas A&M basketball
2 mo ago by Luke Evangelist
Bucky McMillan and the Fightin' Texas Aggies have received the commitment of Spanish forward Rubén Domínguez. Dominguez comes to Aggieland with four years of eligibility left in the NCAA, as the 22-year-old has been playing professionally in Spain.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.